1	Un	Un		C0205447_1	calificador_1	0-2	191_QUEST_clinical_caseMIR	SENT1	-	-
2	hombre	hombre	NCMS000	C0025266#C0086418#C0043210	persona#organismo_vivo	3-9	191_QUEST_clinical_caseMIR	SENT1	-	-
3	de	de	SPS00	C0332285	atributo	10-12	191_QUEST_clinical_caseMIR	SENT1	-	-
4	treinta	treinta		-	-	13-20	191_QUEST_clinical_caseMIR	SENT1	-	-
5	y	y		-	-	21-22	191_QUEST_clinical_caseMIR	SENT1	-	-
6	cinco	cinco		-	-	23-28	191_QUEST_clinical_caseMIR	SENT1	-	-
7	años	año	NCMP000	C0439234	calificador	29-33	191_QUEST_clinical_caseMIR	SENT1	-	-
8	(	(	Fpa	-	-	34-35	191_QUEST_clinical_caseMIR	SENT1	-	-
9	caso	caso	NCMS000	C0868928	calificador	35-39	191_QUEST_clinical_caseMIR	SENT1	-	-
10	índice	índice	NCMS000	-	-	40-46	191_QUEST_clinical_caseMIR	SENT1	-	-
11	)	)	Fpt	-	-	46-47	191_QUEST_clinical_caseMIR	SENT1	-	-
12	afecto	afecto	NCMS000	C0001721	función	48-54	191_QUEST_clinical_caseMIR	SENT1	-	-
13	de	de	SPS00	C0332285	atributo	55-57	191_QUEST_clinical_caseMIR	SENT1	-	-
14	ataxia	ataxia	NCFS000	C0004134	hallazgo	58-64	191_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
15	y	y	CC	C1706368	calificador	65-66	191_QUEST_clinical_caseMIR	SENT1	-	-
16	con	con	SPS00	C0332287	atributo	67-70	191_QUEST_clinical_caseMIR	SENT1	-	-
17	manifestaciones	manifestación	NCFP000	-	-	71-86	191_QUEST_clinical_caseMIR	SENT1	-	-
18	clínicas	clínico	AQ0FP0	C0205210	calificador	87-95	191_QUEST_clinical_caseMIR	SENT1	-	-
19	desde	desde	SPS00	-	-	96-101	191_QUEST_clinical_caseMIR	SENT1	-	-
20	hace	hacer	VMIP3S0	-	-	102-106	191_QUEST_clinical_caseMIR	SENT1	-	-
21	tres	tres		-	-	107-111	191_QUEST_clinical_caseMIR	SENT1	-	-
22	años	año	NCMP000	C0439234	calificador	112-116	191_QUEST_clinical_caseMIR	SENT1	-	-
23	,	,	Fc	-	-	116-117	191_QUEST_clinical_caseMIR	SENT1	-	-
24	presenta	presentar	VMIP3S0	-	-	118-126	191_QUEST_clinical_caseMIR	SENT1	-	-
25	una	una		C0205447_1	calificador_1	127-130	191_QUEST_clinical_caseMIR	SENT1	-	-
26	mutación	mutación	NCFS000	-	-	131-139	191_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
27	expansiva	expansivo	AQ0FS0	-	-	140-149	191_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-
28	trínucleotídica	trínucleotídica	AQ0FS00	-	-	150-165	191_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
29	CAG	cag	NCMS000	-	-	166-169	191_QUEST_clinical_caseMIR	SENT1	I-Calificador	-
30	en	en	SPS00	C1720294#C0332285	calificador#atributo	170-172	191_QUEST_clinical_caseMIR	SENT1	-	-
31	heterocigosis	heterocigosis	NCFN000	-	-	173-186	191_QUEST_clinical_caseMIR	SENT1	-	-
32	en	en	SPS00	C1720294#C0332285	calificador#atributo	187-189	191_QUEST_clinical_caseMIR	SENT1	-	-
33	el	el	DA0MS0	-	-	190-192	191_QUEST_clinical_caseMIR	SENT1	-	-
34	gen	gen	NCMS000	C0017337	sustancia	193-196	191_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
35	ATXN1	ATXN1		-	-	197-202	191_QUEST_clinical_caseMIR	SENT1	I-Calificador	-
36	.	.	Fp	-	-	202-203	191_QUEST_clinical_caseMIR	SENT1	-	-

1	El	el	DA0MS0	-	-	204-206	191_QUEST_clinical_caseMIR	SENT2	-	-
2	diagnóstico	diagnóstico	NCMS000	C0011900	entidad_observable	207-218	191_QUEST_clinical_caseMIR	SENT2	-	-
3	molecular	molecular	AQ0CS0	-	-	219-228	191_QUEST_clinical_caseMIR	SENT2	-	-
4	es	ser	VSIP3S0	-	-	229-231	191_QUEST_clinical_caseMIR	SENT2	-	-
5	de	de	SPS00	C0332285	atributo	232-234	191_QUEST_clinical_caseMIR	SENT2	-	-
6	ataxia	ataxia	NCFS000	C0087012_1	trastorno_1	235-241	191_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
7	espinocerebelosa	espinocerebelosa		C0087012_2	trastorno_2	242-258	191_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
8	tipo	tipo	NCMS000	C0441729_1	calificador_1	259-263	191_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
9	1	1	Z	C0441729_2	calificador_2	264-265	191_QUEST_clinical_caseMIR	SENT2	I-Calificador	-
10	(	(	Fpa	-	-	266-267	191_QUEST_clinical_caseMIR	SENT2	-	-
11	SCA1	SCA1		-	-	267-271	191_QUEST_clinical_caseMIR	SENT2	-	-
12	;	;	Fx	-	-	271-272	191_QUEST_clinical_caseMIR	SENT2	-	-
13	6p22.3	6p22.3		-	-	273-279	191_QUEST_clinical_caseMIR	SENT2	-	-
14	)	)	Fpt	-	-	279-280	191_QUEST_clinical_caseMIR	SENT2	-	-
15	y	y	CC	C1706368	calificador	281-282	191_QUEST_clinical_caseMIR	SENT2	-	-
16	en	en	SPS00	C1720294#C0332285	calificador#atributo	283-285	191_QUEST_clinical_caseMIR	SENT2	-	-
17	el	el	DA0MS0	-	-	286-288	191_QUEST_clinical_caseMIR	SENT2	-	-
18	informe	informe	NCMS000	C0684224	elemento_de_registro	289-296	191_QUEST_clinical_caseMIR	SENT2	-	-
19	genético	genético	AQ0MS0	-	-	297-305	191_QUEST_clinical_caseMIR	SENT2	-	-
20	se	se	P00CN000	-	-	306-308	191_QUEST_clinical_caseMIR	SENT2	-	-
21	dice	decir	VMIP3S0	-	-	309-313	191_QUEST_clinical_caseMIR	SENT2	-	-
22	que	que	CS	-	-	314-317	191_QUEST_clinical_caseMIR	SENT2	-	-
23	la	el	DA0FS0	-	-	318-320	191_QUEST_clinical_caseMIR	SENT2	-	-
24	enfermedad	enfermedad	NCFS000	C0012634#C0039082	trastorno	321-331	191_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
25	es	ser	VSIP3S0	-	-	332-334	191_QUEST_clinical_caseMIR	SENT2	-	-
26	de	de	SPS00	C0332285	atributo	335-337	191_QUEST_clinical_caseMIR	SENT2	-	-
27	penetrancia	penetrancia	NCFS000	-	-	338-349	191_QUEST_clinical_caseMIR	SENT2	-	-
28	completa	completo	AQ0FS0	C0205197#C0439810#C0444868	calificador	350-358	191_QUEST_clinical_caseMIR	SENT2	-	-
29	a	a	SPS00	-	-	359-360	191_QUEST_clinical_caseMIR	SENT2	-	-
30	lo	el	DA0NS0	-	-	361-363	191_QUEST_clinical_caseMIR	SENT2	-	-
31	largo	largo	AQ0MS0	C0205166#C0392744	calificador	364-369	191_QUEST_clinical_caseMIR	SENT2	-	-
32	de	de	SPS00	C0332285	atributo	370-372	191_QUEST_clinical_caseMIR	SENT2	-	-
33	la	el	DA0FS0	-	-	373-375	191_QUEST_clinical_caseMIR	SENT2	-	-
34	vida	vida	NCFS000	-	-	376-380	191_QUEST_clinical_caseMIR	SENT2	-	-
35	.	.	Fp	-	-	380-381	191_QUEST_clinical_caseMIR	SENT2	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	382-384	191_QUEST_clinical_caseMIR	SENT3	-	-
2	el	el	DA0MS0	-	-	385-387	191_QUEST_clinical_caseMIR	SENT3	-	-
3	consejo	consejo	NCMS000	-	-	388-395	191_QUEST_clinical_caseMIR	SENT3	-	-
4	genético	genético	AQ0MS0	-	-	396-404	191_QUEST_clinical_caseMIR	SENT3	-	-
5	se	se	P00CN000	-	-	405-407	191_QUEST_clinical_caseMIR	SENT3	-	-
6	explicarán	explicar	VMIF3P0	-	-	408-418	191_QUEST_clinical_caseMIR	SENT3	-	-
7	al	al	SP+DA	-	-	419-421	191_QUEST_clinical_caseMIR	SENT3	-	-
8	caso	caso	NCMS000	C0868928	calificador	422-426	191_QUEST_clinical_caseMIR	SENT3	-	-
9	índice	índice	NCMS000	-	-	427-433	191_QUEST_clinical_caseMIR	SENT3	-	-
10	los	el	DA0MP0	-	-	434-437	191_QUEST_clinical_caseMIR	SENT3	-	-
11	riesgos	riesgo	NCMP000	-	-	438-445	191_QUEST_clinical_caseMIR	SENT3	-	-
12	de	de	SPS00	C0332285	atributo	446-448	191_QUEST_clinical_caseMIR	SENT3	-	-
13	transmitir	transmitir	VMN0000	-	-	449-459	191_QUEST_clinical_caseMIR	SENT3	-	-
14	la	el	DA0FS0	-	-	460-462	191_QUEST_clinical_caseMIR	SENT3	-	-
15	enfermedad	enfermedad	NCFS000	C0012634#C0039082	trastorno	463-473	191_QUEST_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
16	a	a	SPS00	-	-	474-475	191_QUEST_clinical_caseMIR	SENT3	-	-
17	su	su	DP3CS0	-	-	476-478	191_QUEST_clinical_caseMIR	SENT3	-	-
18	descendencia	descendencia	NCFS000	-	-	479-491	191_QUEST_clinical_caseMIR	SENT3	-	-
19	.	.	Fp	-	-	491-492	191_QUEST_clinical_caseMIR	SENT3	-	-

1	¿	¿	Fia	-	-	493-494	191_QUEST_clinical_caseMIR	SENT4	-	-
2	Qué	qué	PT0CN000	-	-	494-497	191_QUEST_clinical_caseMIR	SENT4	-	-
3	se	se	P00CN000	-	-	498-500	191_QUEST_clinical_caseMIR	SENT4	-	-
4	deduce	deducir	VMIP3S0	-	-	501-507	191_QUEST_clinical_caseMIR	SENT4	-	-
5	de	de	SPS00	C0332285	atributo	508-510	191_QUEST_clinical_caseMIR	SENT4	-	-
6	lo	el	DA0NS0	-	-	511-513	191_QUEST_clinical_caseMIR	SENT4	-	-
7	expuesto	expuesto	NC00SC0	C0332157	calificador	514-522	191_QUEST_clinical_caseMIR	SENT4	-	-
8	?	?	Fit	-	-	522-523	191_QUEST_clinical_caseMIR	SENT4	-	-
9	:	:	Fd	-	-	523-524	191_QUEST_clinical_caseMIR	SENT4	-	-
10	.	.	Fp	-	-	524-525	191_QUEST_clinical_caseMIR	SENT4	-	-

